{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T21:18:51Z","timestamp":1791062331715,"version":"4.1.0"},"reference-count":20,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,20]],"date-time":"2024-09-20T00:00:00Z","timestamp":1726790400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revue Neurologique"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.neurol.2024.08.009","type":"journal-article","created":{"date-parts":[[2024,9,23]],"date-time":"2024-09-23T13:55:33Z","timestamp":1727099733000},"page":"908-915","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["What we\u2019ve learnt about autoimmune neurological diseases from neuropathology"],"prefix":"10.1016","volume":"180","author":[{"given":"S.","family":"Nitsch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"H\u00f6ftberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.neurol.2024.08.009_bib0105","doi-asserted-by":"crossref","first-page":"e200137","DOI":"10.1212\/NXI.0000000000200137","article-title":"Antibodies associated with autoimmune encephalitis in patients with presumed neurodegenerative dementia","volume":"10","author":"Bastiaansen","year":"2023","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1016\/j.neurol.2024.08.009_bib0110","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1002\/ana.26223","article-title":"Neuropathological variability within a spectrum of NMDAR-encephalitis","volume":"90","author":"Zrzavy","year":"2021","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neurol.2024.08.009_bib0115","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1093\/brain\/awac404","article-title":"Temporal lobe epilepsy with GAD antibodies: neurons killed by T cells not by complement membrane attack complex","volume":"146","author":"Tr\u00f6scher","year":"2023","journal-title":"Brain"},{"key":"10.1016\/j.neurol.2024.08.009_bib0120","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000001014","article-title":"Updated diagnostic criteria for paraneoplastic neurologic syndromes","volume":"8","author":"Graus","year":"2021","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1016\/j.neurol.2024.08.009_bib0125","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000200006","article-title":"Paraneoplastic cerebellar degeneration with P\/Q-VGCC vs. Yo autoantibodies","volume":"9","author":"Winklehner","year":"2022","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1016\/j.neurol.2024.08.009_bib0130","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.127001","article-title":"IFN-\u03b3 is a therapeutic target in paraneoplastic cerebellar degeneration","volume":"4","author":"Yshii","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.neurol.2024.08.009_bib0135","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1001\/jamaneurol.2016.2549","article-title":"Autoimmune glial fibrillary acidic protein astrocytopathy: a novel meningoencephalomyelitis","volume":"73","author":"Fang","year":"2016","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.neurol.2024.08.009_bib0140","doi-asserted-by":"crossref","DOI":"10.1007\/s00401-023-02678-7","article-title":"New insights into neuropathology and pathogenesis of autoimmune glial fibrillary acidic protein meningoencephalomyelitis","volume":"147","author":"Guo","year":"2024","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.neurol.2024.08.009_bib0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2023.105517","article-title":"Quantitative analysis of NMDA receptor subunits proteins in mouse brain","volume":"165","author":"Suzuki","year":"2023","journal-title":"Neurochem Int"},{"key":"10.1016\/j.neurol.2024.08.009_bib0150","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/S1474-4422(19)30244-3","article-title":"An update on anti-NMDA receptor encephalitis for neurologists and psychiatrists: mechanisms and models","volume":"18","author":"Dalmau","year":"2019","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.neurol.2024.08.009_bib0155","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000001019","article-title":"Autoimmune global amnesia as manifestation of AMPAR encephalitis and neuropathologic findings","volume":"8","author":"Ricken","year":"2021","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"3","key":"10.1016\/j.neurol.2024.08.009_bib0160","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/S1474-4422(23)00463-5","article-title":"Neurological, psychiatric, and sleep investigations after treatment of antileucine-rich glioma-inactivated protein 1 (LGI1) encephalitis in Spain: a prospective cohort study","volume":"23","author":"Mu\u00f1oz-Lopetegi","year":"2024","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.neurol.2024.08.009_bib0165","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1093\/brain\/aws082","article-title":"Immunopathology of autoantibody-associated encephalitides: clues for pathogenesis","volume":"135","author":"Bien","year":"2012","journal-title":"Brain"},{"issue":"5","key":"10.1016\/j.neurol.2024.08.009_bib0170","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1097\/NEN.0000000000000063","article-title":"IgG and complement deposition and neuronal loss in cats and humans with epilepsy and voltage-gated potassium channel complex antibodies","volume":"73","author":"Klang","year":"2014","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.neurol.2024.08.009_bib0175","doi-asserted-by":"crossref","first-page":"e75","DOI":"10.1212\/NXI.0000000000000075","article-title":"Complement-associated neuronal loss in a patient with CASPR2 antibody-associated encephalitis","volume":"2","author":"K\u00f6rtvelyessy","year":"2015","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"6","key":"10.1016\/j.neurol.2024.08.009_bib0180","doi-asserted-by":"crossref","first-page":"e200298","DOI":"10.1212\/NXI.0000000000200298","article-title":"Progressive Encephalomyelitis with Rigidity and Myoclonus with glycine receptor and GAD65 antibodies: case report and potential mechanisms","volume":"11","author":"Winklehner","year":"2024","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1016\/j.neurol.2024.08.009_bib0185","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S1474-4422(14)70051-1","article-title":"A novel non-rapid-eye movement and rapid-eye-movement parasomnia with sleep breathing disorder associated with antibodies to IgLON5: a case series, characterisation of the antigen, and post-mortem study","volume":"13","author":"Sabater","year":"2014","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.neurol.2024.08.009_bib0190","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s00401-016-1591-8","article-title":"Neuropathological criteria of anti-IgLON5-related tauopathy","volume":"132","author":"Gelpi","year":"2016","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.neurol.2024.08.009_bib0195","article-title":"Patients\u2019 IgLON5 autoantibodies interfere with IgLON5-protein interactions","volume":"14","author":"Landa","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.neurol.2024.08.009_bib0200","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/s00401-023-02625-6","article-title":"Analysis of inflammatory markers and tau deposits in an autopsy series of nine patients with anti-IgLON5 disease","volume":"146","author":"Berger-Sieczkowski","year":"2023","journal-title":"Acta Neuropathol"}],"container-title":["Revue Neurologique"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378724005939?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378724005939?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,31]],"date-time":"2024-10-31T13:35:57Z","timestamp":1730381757000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0035378724005939"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":20,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S0035378724005939"],"URL":"https:\/\/doi.org\/10.1016\/j.neurol.2024.08.009","relation":{},"ISSN":["0035-3787"],"issn-type":[{"value":"0035-3787","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"What we\u2019ve learnt about autoimmune neurological diseases from neuropathology","name":"articletitle","label":"Article Title"},{"value":"Revue Neurologique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurol.2024.08.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}